Yu-mei Feng
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Overexpression of RUNX2 promotes breast cancer multi-organ metastasis through stabilizing c-Myc.
Journal: Cell death & disease
Published: March 10, 2025
FOXF2 expression triggered by endocrine therapy orchestrates therapeutic resistance through reorganization of chromatin architecture in breast cancer.
Journal: Cancer letters
Published: July 03, 2024
Iridoids and sesquiterpenoids from Valeriana officinalis and their bioactivities.
Journal: Phytochemistry
Published: May 01, 2022
Clinical Significance of EBV-DNA Copy Number in EBV Positive Lymphoma Patients
Journal: Zhongguo shi yan xue ye xue za zhi
Published: December 11, 2021
FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
Journal: The Journal of biological chemistry
Published: September 22, 2021
Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.
Journal: British journal of cancer
Published: February 18, 2021
Classification of diffuse lower-grade glioma based on immunological profiling.
Journal: Molecular oncology
Published: February 12, 2020
Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma.
Journal: The Journal of pathology
Published: December 18, 2019
FOXF2 deficiency accelerates the visceral metastasis of basal-like breast cancer by unrestrictedly increasing TGF-β and miR-182-5p.
Journal: Cell death and differentiation
Published: September 24, 2019
Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy.
Journal: OncoTargets and therapy
Published: July 19, 2019
Last Updated: 09/26/2026